Alice Melão,  —

Articles by Alice Melão

PTC Expanding Gene Therapy Portfolio by Buying Agilis Biotherapeutics

PTC Therapeutics announced it will acquire Agilis Biotherapeutics, a company focused on the development of gene therapies targeting rare diseases that affect the central nervous system (CNS). The acquisition will represent an expansion of PTC Therapeutics’ portfolio by including Agilis’ lead product candidate AGIL-AADC, for aromatic L-amino…